巨球蛋白血症伴血清CA125升高2例报告并文献复习。

IF 2.5 4区 医学 Q3 ONCOLOGY Cancer Management and Research Pub Date : 2024-12-04 eCollection Date: 2024-01-01 DOI:10.2147/CMAR.S486584
Huiying Zhao, Ling Qin, Geng Wang, Jianying Li, Yuan Huang, Jie Niu, Xuzhen Qin
{"title":"巨球蛋白血症伴血清CA125升高2例报告并文献复习。","authors":"Huiying Zhao, Ling Qin, Geng Wang, Jianying Li, Yuan Huang, Jie Niu, Xuzhen Qin","doi":"10.2147/CMAR.S486584","DOIUrl":null,"url":null,"abstract":"<p><p>Waldenström macroglobulinemia (WM) is a relatively rare hematological malignancy characterized by serum monoclonal IgM gammopathy and bone marrow infiltration of lymphoma cells (small B lymphocytes, plasmacytoid lymphocytes, or plasma cells). Elevated CA125 is most seen in ovarian cancer or some benign diseases such as pelvic inflammatory disease and endometriosis. No cases of WM combined with elevated CA125 have been reported so far. Here, we report two rare cases of WM with abnormally high CA125 at the onset of illness. Patient 1 had a nine-year history of pulmonary shadow with a moderately increased CA125 level. Subsequently, she was diagnosed with WM-related lung involvement by biopsy. Patient 2 presented with WM manifestation and a significantly elevated CA125 level of unknown significance. Based on bone marrow smear results and serum IgM levels, the diagnosis of WM was established in both patients. After rigorous physical examination, imaging screening, and pathological biopsy, any underlying disease associated with elevated CA125 in both patients was excluded. CA125 and IgM levels decreased with effective treatment for WM, suggesting that abnormally elevated CA125 was related to the progression of macroglobulinemia. Suspicious WM patients with elevated serum CA125 of unknown significance need to be alert to a special manifestation of macroglobulinemia. More clinical concern is needed. At the same time, the clinician could monitor the patient's serum CA125 level changes to assist in the judgment of the efficacy of the original disease. This report extends the understanding of WM and the application of CA125.</p>","PeriodicalId":9479,"journal":{"name":"Cancer Management and Research","volume":"16 ","pages":"1705-1714"},"PeriodicalIF":2.5000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625420/pdf/","citationCount":"0","resultStr":"{\"title\":\"Two Cases of Macroglobulinemia with Elevated Serum CA125: Case Reports and Literature Review.\",\"authors\":\"Huiying Zhao, Ling Qin, Geng Wang, Jianying Li, Yuan Huang, Jie Niu, Xuzhen Qin\",\"doi\":\"10.2147/CMAR.S486584\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Waldenström macroglobulinemia (WM) is a relatively rare hematological malignancy characterized by serum monoclonal IgM gammopathy and bone marrow infiltration of lymphoma cells (small B lymphocytes, plasmacytoid lymphocytes, or plasma cells). Elevated CA125 is most seen in ovarian cancer or some benign diseases such as pelvic inflammatory disease and endometriosis. No cases of WM combined with elevated CA125 have been reported so far. Here, we report two rare cases of WM with abnormally high CA125 at the onset of illness. Patient 1 had a nine-year history of pulmonary shadow with a moderately increased CA125 level. Subsequently, she was diagnosed with WM-related lung involvement by biopsy. Patient 2 presented with WM manifestation and a significantly elevated CA125 level of unknown significance. Based on bone marrow smear results and serum IgM levels, the diagnosis of WM was established in both patients. After rigorous physical examination, imaging screening, and pathological biopsy, any underlying disease associated with elevated CA125 in both patients was excluded. CA125 and IgM levels decreased with effective treatment for WM, suggesting that abnormally elevated CA125 was related to the progression of macroglobulinemia. Suspicious WM patients with elevated serum CA125 of unknown significance need to be alert to a special manifestation of macroglobulinemia. More clinical concern is needed. At the same time, the clinician could monitor the patient's serum CA125 level changes to assist in the judgment of the efficacy of the original disease. This report extends the understanding of WM and the application of CA125.</p>\",\"PeriodicalId\":9479,\"journal\":{\"name\":\"Cancer Management and Research\",\"volume\":\"16 \",\"pages\":\"1705-1714\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-12-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625420/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Management and Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/CMAR.S486584\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Management and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CMAR.S486584","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

Waldenström巨球蛋白血症(macroglobulinemia, WM)是一种相对罕见的血液系统恶性肿瘤,其特征是血清单克隆IgM γ病变和骨髓淋巴瘤细胞(小B淋巴细胞、浆细胞样淋巴细胞或浆细胞)浸润。CA125升高常见于卵巢癌或一些良性疾病,如盆腔炎和子宫内膜异位症。目前还没有WM合并CA125升高的病例报道。在这里,我们报告两例罕见的WM在发病时CA125异常高。患者1有9年的肺影病史,CA125水平中度增高。随后,她被活检诊断为wm相关的肺部受累。患者2表现为WM表现,CA125水平显著升高,意义不明。根据骨髓涂片结果和血清IgM水平,两例患者均确诊为WM。经过严格的体格检查、影像学筛查和病理活检,排除了两例患者中与CA125升高相关的任何潜在疾病。CA125和IgM水平随着WM的有效治疗而降低,提示CA125异常升高与巨球蛋白血症的进展有关。可疑WM患者血清CA125升高意义不明,需警惕巨球蛋白血症的特殊表现。需要更多的临床关注。同时,临床医生可监测患者血清CA125水平变化,协助判断原发疾病的疗效。本报告扩展了对WM和CA125应用的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Two Cases of Macroglobulinemia with Elevated Serum CA125: Case Reports and Literature Review.

Waldenström macroglobulinemia (WM) is a relatively rare hematological malignancy characterized by serum monoclonal IgM gammopathy and bone marrow infiltration of lymphoma cells (small B lymphocytes, plasmacytoid lymphocytes, or plasma cells). Elevated CA125 is most seen in ovarian cancer or some benign diseases such as pelvic inflammatory disease and endometriosis. No cases of WM combined with elevated CA125 have been reported so far. Here, we report two rare cases of WM with abnormally high CA125 at the onset of illness. Patient 1 had a nine-year history of pulmonary shadow with a moderately increased CA125 level. Subsequently, she was diagnosed with WM-related lung involvement by biopsy. Patient 2 presented with WM manifestation and a significantly elevated CA125 level of unknown significance. Based on bone marrow smear results and serum IgM levels, the diagnosis of WM was established in both patients. After rigorous physical examination, imaging screening, and pathological biopsy, any underlying disease associated with elevated CA125 in both patients was excluded. CA125 and IgM levels decreased with effective treatment for WM, suggesting that abnormally elevated CA125 was related to the progression of macroglobulinemia. Suspicious WM patients with elevated serum CA125 of unknown significance need to be alert to a special manifestation of macroglobulinemia. More clinical concern is needed. At the same time, the clinician could monitor the patient's serum CA125 level changes to assist in the judgment of the efficacy of the original disease. This report extends the understanding of WM and the application of CA125.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer Management and Research
Cancer Management and Research Medicine-Oncology
CiteScore
7.40
自引率
0.00%
发文量
448
审稿时长
16 weeks
期刊介绍: Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include: ◦Epidemiology, detection and screening ◦Cellular research and biomarkers ◦Identification of biotargets and agents with novel mechanisms of action ◦Optimal clinical use of existing anticancer agents, including combination therapies ◦Radiation and surgery ◦Palliative care ◦Patient adherence, quality of life, satisfaction The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.
期刊最新文献
Clinical Significance of the Peripheral Blood Neutrophil-to-Lymphocyte Ratio in Predicting Chemotherapy Outcomes for Small Cell Lung Cancer. Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3). ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung Cancer. Impact of Radiation Therapy Techniques on Hippocampal Doses and Psychological Status in Patients With Nasopharyngeal Carcinoma. Successful Diagnosis and Management of Superior Orbital Fissure Syndrome Secondary to Lung Adenocarcinoma: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1